COVID-19 and Parkinson's Disease: Are We Dealing with Short-term Impacts or Something Worse?

Affiliations

Comment

Daniella Balduino Victorino et al. J Parkinsons Dis. 2020.

. 2020;10(3):899-902.

doi: 10.3233/JPD-202073.

¹ Department of Neurology and Neurosurgery, Discipline of Neuroscience, Federal University of São Paulo/Paulista Medical School, São Paulo, SP, Brazil.

No abstract available

Conflict of interest statement

The authors report no conflicts of interest.

The Impact of the COVID-19 Pandemic on Parkinson's Disease: Hidden Sorrows and Emerging Opportunities.
Helmich RC, Bloem BR. Helmich RC, et al. J Parkinsons Dis. 2020;10(2):351-354. doi: 10.3233/JPD-202038. J Parkinsons Dis. 2020. PMID: 32250324 Free PMC article. No abstract available.

1. Helmich RC, Bloem BR (2020) The Impact of the COVID-19 Pandemic on Parkinson’s Disease: Hidden Sorrows and Emerging Opportunities. J Parkinsons Di 10, 351–354. - PMC - PubMed
1. Conde G, Quintana Pájaro LD, Quintero Marzola ID, Villegas YR, Moscote Salazar LR (2020) Neurotropism of SARS-CoV 2: Mechanisms and manifestations. J Neurol Sci, 116824. - PMC - PubMed
1. Li YC, Bai WZ, Hashikawa T (2020) The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol [Epub ahead of print]. - PMC - PubMed
1. Cain MD, Salimi H, Diamond MS, Klein RS (2019) Mechanisms of Pathogen Invasion into the Central Nervous System. Neuron 103, 771–783. - PubMed
1. Dubé M, Le Coupanec A, Wong AHM, Rini JM, Desforges M, Talbot PJ (2018) Axonal Transport Enables Neuron-to-Neuron Propagation of Human Coronavirus OC43. J Virol 16, pii: e00404–18. - PMC - PubMed